A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer

Published:2014-08-29 Issue:15 Volume:74 Page:1544-1550
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Azad Arun A.¹,Leibowitz-Amit Raya²,Eigl Bernhard J.¹,Lester Renee³,Wells J. Connor³,Murray R. Nevin¹,Kollmannsberger Christian¹,Heng Daniel Y.C.³,Joshua Anthony M.²,Chi Kim N.¹

Affiliation:

1. Department of Medical Oncology; British Columbia Cancer Agency; Vancouver British Columbia Canada

2. Department of Medical Oncology and Haematology; Princess Margaret Cancer Centre; Toronto Ontario Canada

3. Tom Baker Cancer Centre; University of Calgary; Calgary Alberta Canada

Publisher

Wiley

Subject

Urology,Oncology

Reference17 articles.

1. Castration-resistant prostate cancer: From new pathophysiology to new treatment;Sridhar;Eur Urol,2014

2. Global cancer statistics;Jemal;CA Cancer J Clin,2011

3. Castration-resistant prostate cancer: From new pathophysiology to new treatment targets;Chi;Eur Urol,2009